Of interest, ophthalmologist Barry Linder, MD, MS, has developed an instrument for the management of OSD. This facial masklike device, which is under investigation but… Read More »That’s some nerve! Ocular drug delivery and dry eye
Report From ESCRS Barcelona: Discover the Eye Lipid Mobilizer® (ELM) Meta Description: Learn about the Eye Lipid Mobilizer®, an innovative solution for chronic dry eye,… Read More »Report From ESCRS Barcelona: Discover the Eye Lipid Mobilizer (ELM)
DANVILLE, CA – Eyedetec Medical, Inc., a medical device company focused on developing innovative, next-generation treatments for dry eye disease, announced the appointment of Tom… Read More »Senior Ophthalmology Executive Thomas A. (Tom) Dunlap joins Eyedetec Medical, Inc. as an independent member of the Board of Directors to support the company’s business development and commercialization initiatives within the Optometric and Ophthalmic markets.
MEETING REPORTER: Barry Linder, MD, at Eyecelerator 2024 unveils the groundbreaking ELM® (iLipid Mobilizer®) technology developed by Eyedetec Medical. This innovative solution brings a new… Read More »Eye News Media
Inviting the public to invest in the revolutionary solution to chronic dry eye disease USA, [April 2, 2024]—Eyedetec Medical, Inc., the pioneers behind ELM® (Eye… Read More »Invest in Eyedetec: Changing the Future of Dry Eye Therapy
Zhaoke Ophthalmology Limited, a leading ophthalmic pharmaceutical company dedicated to the research and development, manufacturing and commercialization of therapies that address significant unmet medical needs,… Read More »Zhaoke Ophthalmology Enters into Exclusive License, Supply and Distribution Agreement with Eyedetec Medical to Commercialize Eye Lipid Mobilizer® for the Treatment of Dry Eye Disease
The ELM™ is not currently commercially available for sale in the U.S.